• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中报告淋巴管血管侵犯的诊断一致性。

Diagnostic concordance of reporting lymphovascular invasion in breast cancer.

机构信息

Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK.

Histopathology Department, Faculty of Medicine, Menoufia University, Shabeen El Kom, Egypt.

出版信息

J Clin Pathol. 2018 Sep;71(9):802-805. doi: 10.1136/jclinpath-2017-204981. Epub 2018 Mar 29.

DOI:10.1136/jclinpath-2017-204981
PMID:29599396
Abstract

AIMS

This study aims to assess the diagnostic agreement of lymphovascular invasion (LVI) in invasive breast cancer (BC).

METHODS

Data on LVI were collected from the UK National Health Service Breast Screening Programme pathology external quality assurance scheme database. 101 BCs assessed over a 10-year period (2004-2014) were included. Cases were scored by an average of 600 pathologists. Three H&E stained slides from each case were reviewed by three pathologists and additional variables were evaluated.

RESULTS

In the whole series, the overall κ value was 0.4 (range 0.26-0.53). On review, LVI was detected in all three slides in 20 cases (20%), in two slides in 12 cases and in one of the three slides in 9 cases and was not seen in 60 cases. For concordance analysis, the first and last groups were used to represent cases with definite (LVI+) and absent LVI (LVI-), respectively. In the LVI+group (n=20), the level of agreement ranged from 0.54 to 0.99 (median 0.86). In the LVI- group (n=60), the level of agreement ranged from 0.52 to 1.00 (median 0.93), with 44% of cases showing interobserver concordance of >95%. There was a correlation between increasing number of involved lymphovascular spaces in the section and higher LVI reporting concordance. Some degree of retraction/fixation artefacts was observed in 35% of cases; this was associated with a lower concordance rate.

CONCLUSIONS

The concordance of reporting LVI is variable. Cases without LVI and those with multiple involved vessels are likely to have the highest concordance and the highest detection rates.

摘要

目的

本研究旨在评估浸润性乳腺癌(BC)中淋巴血管侵犯(LVI)的诊断一致性。

方法

从英国国家医疗服务体系乳腺筛查计划病理学外部质量保证计划数据库中收集 LVI 数据。纳入了在 10 年期间(2004-2014 年)评估的 101 例 BC 病例。由平均 600 位病理学家对这些病例进行评分。每位病理学家对每个病例的三张 H&E 染色切片进行了审查,并评估了其他变量。

结果

在整个系列中,整体 κ 值为 0.4(范围 0.26-0.53)。在复查中,20 例(20%)在所有三张切片中均检测到 LVI,12 例中有 2 张切片中检测到 LVI,9 例中有 1 张切片中检测到 LVI,60 例中未检测到 LVI。为了进行一致性分析,将第一组和最后一组分别代表明确存在 LVI(LVI+)和不存在 LVI(LVI-)的病例。在 LVI+组(n=20)中,一致性水平范围为 0.54 至 0.99(中位数 0.86)。在 LVI-组(n=60)中,一致性水平范围为 0.52 至 1.00(中位数 0.93),其中 44%的病例具有>95%的观察者间一致性。切片中受累的淋巴管和血管数量增加与 LVI 报告一致性提高有关。35%的病例观察到某种程度的回缩/固定伪影,这与较低的一致性率相关。

结论

报告 LVI 的一致性是可变的。无 LVI 且有多个受累血管的病例可能具有最高的一致性和最高的检出率。

相似文献

1
Diagnostic concordance of reporting lymphovascular invasion in breast cancer.乳腺癌中报告淋巴管血管侵犯的诊断一致性。
J Clin Pathol. 2018 Sep;71(9):802-805. doi: 10.1136/jclinpath-2017-204981. Epub 2018 Mar 29.
2
Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme.乳腺病理学家的诊断一致性:来自国民保健服务乳腺筛查计划病理学外部质量保证计划的经验教训。
Histopathology. 2017 Mar;70(4):632-642. doi: 10.1111/his.13117. Epub 2016 Dec 28.
3
Lymphovascular invasion in colorectal cancer: an interobserver variability study.结直肠癌中的淋巴管浸润:一项观察者间变异性研究。
Am J Surg Pathol. 2008 Dec;32(12):1816-21. doi: 10.1097/PAS.0b013e3181816083.
4
Review of the national external quality assessment (EQA) scheme for breast pathology in the UK.英国乳腺病理学国家外部质量评估(EQA)计划综述
J Clin Pathol. 2017 Jan;70(1):51-57. doi: 10.1136/jclinpath-2016-203800. Epub 2016 Jul 12.
5
Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study.鉴别乳腺癌中的血管和淋巴管侵犯:一项前瞻性免疫组织化学研究。
Br J Cancer. 2006 Jun 5;94(11):1643-9. doi: 10.1038/sj.bjc.6603152.
6
Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.目的评估淋巴结阴性乳腺癌的淋巴管和血管侵犯:一项大型病例系列研究的长期随访结果。
J Pathol. 2011 Feb;223(3):358-65. doi: 10.1002/path.2810. Epub 2010 Dec 6.
7
Blood and lymphatic vessel invasion in pT1 colorectal cancer: an international concordance study.pT1期结直肠癌的血管及淋巴管侵犯:一项国际一致性研究
J Clin Pathol. 2015 Aug;68(8):628-32. doi: 10.1136/jclinpath-2014-202805. Epub 2015 Apr 30.
8
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer.大型2.04 MRC/EORTC SUPREMO试验:一项针对中危乳腺癌乳房切除术后放疗的大型3期随机国际临床试验的病理质量保证
Breast Cancer Res Treat. 2017 May;163(1):63-69. doi: 10.1007/s10549-017-4145-4. Epub 2017 Feb 11.
9
The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases.浸润性乳腺癌中广泛退缩裂隙的存在与淋巴浸润和淋巴结转移相关,并预示预后不良:一项对2742例连续病例的前瞻性验证研究。
Am J Surg Pathol. 2015 Mar;39(3):325-37. doi: 10.1097/PAS.0000000000000339.
10
Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.D2-40(血小板内皮细胞黏附分子)检测早期乳腺癌中的淋巴管浸润:腋窝淋巴结转移的临床有用预测指标
Breast Cancer Res Treat. 2008 Dec;112(3):503-11. doi: 10.1007/s10549-007-9875-2. Epub 2007 Dec 29.

引用本文的文献

1
Deep learning assisted non-invasive lymph node burden evaluation and CDK4/6i administration in luminal breast cancer.深度学习辅助的管腔型乳腺癌非侵入性淋巴结负荷评估及CDK4/6抑制剂给药
iScience. 2025 Jun 7;28(7):112849. doi: 10.1016/j.isci.2025.112849. eCollection 2025 Jul 18.
2
Establishment of a predictive nomogram for breast cancer lympho-vascular invasion based on radiomics obtained from digital breast tomography and clinical imaging features.基于数字乳腺断层摄影获得的影像组学和临床影像特征建立乳腺癌淋巴管侵犯的预测列线图。
BMC Med Imaging. 2025 Feb 26;25(1):65. doi: 10.1186/s12880-025-01607-2.
3
Deep Learning Predicts Lymphovascular Invasion Status in Muscle Invasive Bladder Cancer Histopathology.
深度学习预测肌层浸润性膀胱癌组织病理学中的淋巴管浸润状态。
Ann Surg Oncol. 2025 Jan;32(1):598-608. doi: 10.1245/s10434-024-16422-2. Epub 2024 Oct 29.
4
Machine learning based on optimal VOI of multi-sequence MR images to predict lymphovascular invasion in invasive breast cancer.基于多序列磁共振成像最佳感兴趣区的机器学习预测浸润性乳腺癌的淋巴管侵犯
Heliyon. 2024 Apr 6;10(7):e29267. doi: 10.1016/j.heliyon.2024.e29267. eCollection 2024 Apr 15.
5
Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma.CD34免疫染色增加了肝细胞癌微血管侵犯分析的特异性。
J Hepatocell Carcinoma. 2023 Jan 22;10:91-98. doi: 10.2147/JHC.S389836. eCollection 2023.
6
The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.细胞周期蛋白 B1(CCNB1)在浸润性乳腺癌中的临床意义,重点探讨其对淋巴管血管侵犯发展的作用。
Breast Cancer Res Treat. 2023 Apr;198(3):423-435. doi: 10.1007/s10549-022-06801-2. Epub 2022 Nov 22.
7
Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer.人类乳腺癌中的淋巴管内皮标志物与肿瘤淋巴管生成评估
Diagnostics (Basel). 2021 Dec 21;12(1):4. doi: 10.3390/diagnostics12010004.
8
Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.淋巴管侵犯的转录组特征,胰腺导管腺癌转移的已知危险因素
Cancers (Basel). 2020 Jul 24;12(8):2033. doi: 10.3390/cancers12082033.
9
Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.乳腺癌中的淋巴管侵犯与细胞增殖的基因表达特征相关,但与淋巴管生成或免疫反应无关。
Breast Cancer Res Treat. 2020 Jun;181(2):309-322. doi: 10.1007/s10549-020-05630-5. Epub 2020 Apr 13.
10
A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.与浸润性乳腺癌淋巴管血管侵犯相关的关键基因组亚型。
Br J Cancer. 2019 Jun;120(12):1129-1136. doi: 10.1038/s41416-019-0486-6. Epub 2019 May 22.